Indefinite Delivery Contract SPE2D219D0063

Award Date 11/5/18
Last Date to Order 11/4/23
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The federal contract IDV awarded to Prasco, LLC, a pharmaceutical company based in Mason, Ohio, is a single-award Indefinite Delivery Contract with the Department of Veterans Affairs (VA) valued at $31,715,011.75. The contract, which runs through June 2034, allows multiple federal agencies, including the Centers for Disease Control and Prevention (CDC) and the Medical Supply Chain, to place task orders for a wide range of pharmaceutical manufacturing and distribution services. Prasco has been...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a $999,999,999 single award Indefinite Delivery Contract (IDC) to Amerisourcebergen Drug Corp to provide a comprehensive range of pharmaceutical products and medical supplies in support of military healthcare programs globally. This IDC, which runs through December 2036, serves as a primary vehicle for procuring specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic...
The Defense Logistics Agency (DLA) Troop Support Medical awarded an Indefinite Delivery Contract (IDC) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide worldwide pharmaceutical and medical supply support to the Department of Defense (DoD), United States Coast Guard, and other government agencies. The $4,999,999 single-award IDC has a period of performance through December 2036 and was issued without any set-asides. The contract aims to establish Pharmaceutical Prime...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded an indefinite delivery contract (IDC) to DMS Pharmaceutical Group Inc., a woman-owned small business, valued at up to $499,999,999 to provide a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of military healthcare facilities worldwide. The contract, under the SPE2DB program, enables DLA to issue firm fixed-price delivery orders for branded and generic prescription...
The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain has awarded a $999,999,999 Indefinite Delivery Contract (IDC) to Amerisourcebergen Drug Corp to provide a comprehensive range of pharmaceutical products and medical supplies supporting military healthcare programs globally. This single-award IDC has a period of performance through December 2036 and will serve as a primary vehicle for the DLA to procure specialty medications, brand-name and generic drugs, vaccines, syringes,...
The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain has awarded a single-award Indefinite Delivery Contract (IDC) valued at $4,999,999 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, to provide a comprehensive range of pharmaceutical products and medical supplies to various Department of Defense (DoD) customers. The IDC covers an extensive portfolio of pharmaceutical items, including branded and generic prescription drugs,...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a single-award Indefinite Delivery Contract (IDC) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide a comprehensive range of pharmaceutical and medical supply products to support military healthcare programs globally. The $999,999,999 IDC has a 30-month base period and three 30-month option periods, with an estimated total value of $30.3 billion across multiple regional awards. The contract is...
The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain has awarded a single-award Indefinite Delivery Contract (IDC) to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide a comprehensive range of pharmaceutical products and medical supplies to support the medical needs of military healthcare facilities and veterans' centers nationwide. The $4,999,999 IDC, valid through December 2036, enables DLA to issue firm fixed-price delivery orders for branded and generic...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a single-award Indefinite Delivery Contract (IDC) valued up to $999,999,999 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide a comprehensive range of pharmaceutical products and medical supplies. This IDC serves as the primary vehicle for AmerisourceBergen to deliver critical medical commodities, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to...
The U.S. Defense Logistics Agency (DLA) awarded a single-award Indefinite Delivery Contract (IDC) valued at $499,999,999 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, to provide a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of military healthcare facilities and veterans' medical centers nationwide. The IDC, valid through November 2026, covers an extensive portfolio of branded and generic...

The Defense Logistics Agency (DLA) Troop Support Medical awarded a single-award Indefinite Delivery Contract (IDC) to Prasco, LLC, a for-profit limited liability company, on November 5, 2018. The contract, which has a potential value of $18,283,585.45, is for the manufacture and distribution of pharmaceutical products such as sodium fluoride dental gel and atovaquone/proguanil tablets. These products are provided to U.S. federal government agencies, including the Department of Veterans Affairs and the Centers for Disease Control and Prevention, to support their pharmacy programs and disease prevention efforts globally. The contract was awarded as a commercial item purchase without any set-aside provisions, with performance taking place at Prasco's headquarters in Mason, Ohio. The original solicitation, posted on January 17, 2017, was for a national requirements contract for atovaquone proguanil HCL tablets, with an estimated annual usage to be provided in the Schedule of Supplies section.

The IDC has a base period of one year and four one-year option periods, with a last date to order of November 4, 2023. Under this IDV, the CDC has awarded Prasco multiple firm fixed price delivery orders for atovaquone/proguanil tablets, each worth approximately $24,000-$26,000, to support global disease prevention programs. Prasco also holds a separate $359 million IDC against the Pharmaceuticals and Drugs Federal Supply Schedule from July 2021 through June 2026, under which the CDC has placed similar delivery orders.

Generated 3/30/24, 9:12 AM